Upgrade to SI Premium - Free Trial

JPMorgan Reiterates Overweight Rating on Abbott Labs (ABT)

April 16, 2025 8:42 AM
JPMorgan analyst Robbie Marcus reiterated an Overweight rating and $135.00 price target on Abbott Labs (NYSE: ABT).The analyst comments "Abbott ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments

Next Articles